MG
CVRS

Michael Gelband’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Michael Gelband’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,800
Closed -$50K – 1780
2019
Q2 		$50K Sell
16,800
-193,327
-92% -$484K ﹤0.01% 1053
2019
Q1 		$366K Buy
210,127
+128,727
+158% +$178K 0.03% 410
2018
Q4 		$68K Buy
+81,400
New +$97.1K ﹤0.01% 324

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $50.9M AUM 22.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $383M AUM 123.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $244M AUM 110.95% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Michael Gelband's CVRS Position: Q3 2019 in Review

Michael Gelband sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q3 2019, closing a stake of 16,800 shares — an estimated $50K sold.

Michael Gelband first reported a position in CVRS in Q4 2018 and held it in 3 quarters. The position peaked at $366K in Q1 2019. 101 funds tracked by Wall St. Rank hold CVRS as of Q3 2019.

  • Michael Gelband reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q3 2019 after selling out during the quarter.
  • Michael Gelband sold 16,800 CORINDUS VASCULAR ROBOTICS, INC shares in Q3 2019, an estimated $50K.
  • Michael Gelband first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q4 2018 and held it in 3 quarters.
  • Michael Gelband's CORINDUS VASCULAR ROBOTICS, INC position peaked at $366K in Q1 2019.
  • 101 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q3 2019.

Based on ExodusPoint Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.